430 related articles for article (PubMed ID: 26095183)
21. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
[TBL] [Abstract][Full Text] [Related]
22. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
[TBL] [Abstract][Full Text] [Related]
23. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model.
Anfuso B; El-Khobar KE; Ie SI; Avellini C; Radillo O; Raseni A; Tiribelli C; Sukowati CHC
Sci Rep; 2018 Sep; 8(1):13168. PubMed ID: 30177788
[TBL] [Abstract][Full Text] [Related]
24. CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells.
Ke AW; Shi GM; Zhou J; Huang XY; Shi YH; Ding ZB; Wang XY; Devbhandari RP; Fan J
Gastroenterology; 2011 May; 140(5):1629-41.e15. PubMed ID: 21320503
[TBL] [Abstract][Full Text] [Related]
25. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
26. CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Oyama Y; Shigeta S; Tokunaga H; Tsuji K; Ishibashi M; Shibuya Y; Shimada M; Yasuda J; Yaegashi N
PLoS One; 2021; 16(6):e0251079. PubMed ID: 34161330
[TBL] [Abstract][Full Text] [Related]
27. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
Niehof M; Borlak J
Gastroenterology; 2008 Apr; 134(4):1191-202. PubMed ID: 18395097
[TBL] [Abstract][Full Text] [Related]
28. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
Li M; Mu XD; Song JR; Zhai PT; Cheng Y; Le Y; Li ZB
Cell Cycle; 2021 May; 20(10):1010-1020. PubMed ID: 33970778
[TBL] [Abstract][Full Text] [Related]
29. Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer.
Ho DW; Tsui YM; Sze KM; Chan LK; Cheung TT; Lee E; Sham PC; Tsui SK; Lee TK; Ng IO
Cancer Lett; 2019 Sep; 459():176-185. PubMed ID: 31195060
[TBL] [Abstract][Full Text] [Related]
30. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
31. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
Bae JS; Noh SJ; Jang KY; Park HS; Chung MJ; Park CK; Moon WS
Int J Oncol; 2012 Dec; 41(6):2150-8. PubMed ID: 22993038
[TBL] [Abstract][Full Text] [Related]
32. CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
Chang CL; Huang CR; Chang SJ; Wu CC; Chen HH; Luo CW; Yip HK
Int J Biol Sci; 2021; 17(7):1660-1670. PubMed ID: 33994851
[TBL] [Abstract][Full Text] [Related]
33. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.
Cheung ST; Cheung PF; Cheng CK; Wong NC; Fan ST
Gastroenterology; 2011 Jan; 140(1):344-55. PubMed ID: 20682318
[TBL] [Abstract][Full Text] [Related]
34. CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis.
Wu J; Zhou Z; Li J; Liu H; Zhang H; Zhang J; Huang W; He Y; Zhu S; Huo M; Liu M; Zhang C
Drug Resist Updat; 2023 Jan; 66():100913. PubMed ID: 36603431
[TBL] [Abstract][Full Text] [Related]
35. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
Yamashita T; Ji J; Budhu A; Forgues M; Yang W; Wang HY; Jia H; Ye Q; Qin LX; Wauthier E; Reid LM; Minato H; Honda M; Kaneko S; Tang ZY; Wang XW
Gastroenterology; 2009 Mar; 136(3):1012-24. PubMed ID: 19150350
[TBL] [Abstract][Full Text] [Related]
36. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
37. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
38. Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM
Takai A; Dang H; Oishi N; Khatib S; Martin SP; Dominguez DA; Luo J; Bagni R; Wu X; Powell K; Ye QH; Jia HL; Qin LX; Chen J; Mitchell GA; Luo X; Thorgeirsson SS; Wang XW
Cancer Res; 2019 May; 79(9):2379-2391. PubMed ID: 30862714
[TBL] [Abstract][Full Text] [Related]
39. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.
Hu Z; Cao X; Fang Y; Liu G; Xie C; Qian K; Lei X; Cao Z; Du H; Cheng X; Xu X
Biomed Pharmacother; 2018 Sep; 105():697-706. PubMed ID: 29906748
[TBL] [Abstract][Full Text] [Related]
40. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]